Althera and Bruno Farmaceutici Sign Strategic Licensing Agreement to Bring Advanced Type 2 Diabetes Therapy to Italy
Partnership leverages Bruno Farmaceutici’s robust commercial leadership to launch Althera’s innovative Type 2 Diabetes combination therapy DUBLIN, DUBLIN, IRELAND, January 30, 2026 /EINPresswire.com/ -- Althera Laboratories Limited, a global …